Idera Pharmaceutical News (AMEX:IDP)

Idera Pharmaceutical stock quote | Idera Pharmaceutical company information | Idera Pharmaceutical Stock Chart | Idera Pharmaceutical Stock News

Latest Idera Pharmaceutical News Headlines

Date

Time

Source

Headline

01/22/2007

9:00AM

PRNUS

American Stock Exchange to Host First Annual Healthcare Conference in Boston on February 8, 2007
Leading Healthcare Companies Scheduled to Present NEW YORK, Jan. 22 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today announced that it will host its First Annual Healthcare Investor Conference in Boston on Thursday, February 8, 2007. Companies scheduled to present include leading Amex-listed healthcare... More...>>

11/03/2005

8:05AM

PRNUS

Idera Pharmaceuticals to Present at Rodman and Renshaw Techvest 7th Annual Healthcare Conference
CAMBRIDGE, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Idera Pharmaceuticals, Inc. (AMEX:IDP) announced today that Timothy Sullivan, Ph.D., Vice President of Development Programs, is scheduled to present an overview of the Company, its product pipeline, and its technology to investors at the Rodman & Renshaw Techvest 7th... More...>>

10/26/2005

8:05AM

PRNUS

Idera Pharmaceuticals Initiates Phase 1/2 Oncology Trial of HYB2055 in Combination with Chemotherapy Agents Gemcitabine and Carb
Study to be Conducted at Georgetown University Medical Center Includes Phase 2 Component in First-Line Non-Small Cell Lung Cancer CAMBRIDGE, Mass., Oct. 26 /PRNewswire-FirstCall/ -- Idera Pharmaceuticals, Inc. (AMEX:IDP) announced today that it has initiated a new Phase 1/2 clinical trial of HYB2055 in combination with... More...>>

10/20/2005

8:05AM

PRNUS

Idera Pharmaceuticals Amends HYB2055 Phase 2 Renal Cell Carcinoma Protocol
Amendment to Accommodate Increased Enrollment of Treatment-Naive Patients CAMBRIDGE, Mass., Oct. 20 /PRNewswire-FirstCall/ -- Idera Pharmaceuticals, Inc. (AMEX:IDP) announced today that it has submitted to the U.S. Food & Drug Administration a protocol amendment for its ongoing Phase 2 trial of HYB2055 in patients with... More...>>

10/18/2005

8:05AM

PRNUS

Idera Pharmaceuticals to Present at BIO InvestorForum
CAMBRIDGE, Mass., Oct. 18 /PRNewswire-FirstCall/ -- Idera Pharmaceuticals, Inc. (AMEX:IDP) announced today that Sudhir Agrawal, D. Phil, Chief Executive Officer and Chief Scientific Officer of Idera Pharmaceuticals, Inc. will present an overview of the Company, its product pipeline and its technology to investors at... More...>>